These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4683045

  • 1. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
    Catalona WJ, Sample WF, Chretien PB.
    Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045
    [No Abstract] [Full Text] [Related]

  • 2. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients.
    Chretien PB, Crowder WL, Gertner HR, Sample WF, Catalona WJ.
    Surg Gynecol Obstet; 1973 Mar; 136(3):380-4. PubMed ID: 4688801
    [No Abstract] [Full Text] [Related]

  • 3. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB, Catalona WJ, Twomey PL, Sample WF.
    Ann Clin Lab Sci; 1974 Mar; 4(5):331-8. PubMed ID: 4851196
    [No Abstract] [Full Text] [Related]

  • 4. Proceedings: Cellular immunity in cured cancer patients.
    Twomey PL, Catalona WJ, Chretien PB.
    Cancer; 1974 Feb; 33(2):435-40. PubMed ID: 4812762
    [No Abstract] [Full Text] [Related]

  • 5. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ, Chretien PB.
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB, Twomey PL, Trahan EE, Catalona WJ.
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
    Sample WF, Gertner HR, Chretien PB.
    J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
    [No Abstract] [Full Text] [Related]

  • 8. Proceedings: Evaluation of immune status in tumor patients.
    Vetto RM, Burger DR, Lilley DP.
    Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
    [No Abstract] [Full Text] [Related]

  • 9. Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.
    Hellström I, Hellström KE, Warner GA.
    Int J Cancer; 1973 Sep 15; 12(2):348-53. PubMed ID: 4792348
    [No Abstract] [Full Text] [Related]

  • 10. Cellular and humoral immunity to different types of human neoplasms.
    Hellström I, Hellström KE, Pierce GE, Yang JP.
    Nature; 1968 Dec 28; 220(5174):1352-4. PubMed ID: 4302696
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for immune reactivity against neoplasms.
    McKhann CF, Jagarlamoody SM.
    Transplant Rev; 1971 Dec 28; 7():55-77. PubMed ID: 4112673
    [No Abstract] [Full Text] [Related]

  • 12. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T, Takita H.
    Cancer; 1972 Sep 28; 30(3):616-20. PubMed ID: 4342406
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical significance of the subsets of lymphocyte in the peripheral blood of the head and neck cancer patients].
    Okamoto M, Takahashi H, Yao K, Fujino A, Ishii T, Harada K, Yagi A, Yoshio S, Yagi K, Furusawa S.
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr 28; 88(4):443-8. PubMed ID: 4032110
    [No Abstract] [Full Text] [Related]

  • 14. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM, Barna B, Deodhar SD, Hewlett JS.
    Cancer; 1976 Nov 28; 38(5):1962-7. PubMed ID: 991109
    [Abstract] [Full Text] [Related]

  • 15. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ, Coulthard SW, Quaiman SJ, Schork MA.
    Cancer Res; 1977 Dec 28; 37(12):4475-81. PubMed ID: 144562
    [No Abstract] [Full Text] [Related]

  • 16. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP, Chretien PB.
    Semin Oncol; 1977 Dec 28; 4(4):431-9. PubMed ID: 339354
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM, Aziz M, Rattan A, Ahmad KN.
    Indian J Cancer; 1989 Sep 28; 26(3):137-44. PubMed ID: 2630426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.